NCT04066777View on ClinicalTrials.gov

The Effect of TASH in Patients With HOCM

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 29, 2019

Primary Completion Date

October 1, 2023

Study Completion Date

October 1, 2023

Conditions
Hypertrophic Obstructive Cardiomyopathy
Interventions
PROCEDURE

alcohol septal ablation

injection of 1-4 mL of 96% ethanol into a septal perforator of the left anterior coronary artery to produce a myocardial infarction

Trial Locations (1)

8200

Aarhus University Hospital, Department of Cardiology, Aarhus N

All Listed Sponsors
lead

Steen Hvitfeldt Poulsen

OTHER

NCT04066777 - The Effect of TASH in Patients With HOCM | Biotech Hunter | Biotech Hunter